Multiple Manufacturers

OFIRMEV

Manufacturer:

Multiple Manufacturers

Ofirmev HCPCS:

J0131

HCPCS Code Descriptor:

Injection, acetaminophen, not otherwise specified,10 mg

Category:

J Code

Ofirmev NDCs:

67457-0940-10, 24201-0100-24, 55150-0307-24, 36000-0306-60, 00781-3156-95, 72572-0050-10, 72572-0050-01, 72603-0173-24, 72603-0173-10, 24201-0110-24, 00781-9274-95

Primary Type:

Non-Opiod Analgesic

Generic/Specialty Status:

Multi-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

67457-0940-10, 24201-0100-24, 55150-0307-24, 36000-0306-60, 00781-3156-95, 72572-0050-10, 72603-0173-24, 72603-0173-10, 24201-0110-24, 00781-9274-95

About Ofirmev:

OFIRMEV is a medication manufactured by multiple manufacturers and aligned to the J Code: J0131. OFIRMEV is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J0131 Added Date:

January 1, 2012

J0131 Effective Date:

January 1, 2023

J0131 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ofirmev billing and coding information.
Our team did not identify a source for Ofirmev patient assistance information. Please reach out to our team if you feel that this is a mistake.
OFIRMEV prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for OFIRMEV. Please check back in a few weeks.